Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
36.00
133.00
177.00
262.00
201.00
287.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-124.00
-135.00
-62.00
-39.00
-111.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-16.00
78.00
192.00
324.00
121.00
298.00
Cash Flow from Investing Activities
-25.00
-50.00
-112.00
-428.00
-56.00
-225.00
Cash Flow from Financing Activities
-109.00
-131.00
13.00
-121.00
857.00
-86.00
Net Cash Inflow / Outflow
-151.00
-103.00
93.00
-226.00
921.00
-12.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
36.8757192570224
941.160075940648
-905.00
-96.08%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-124.058894620789
1253.24314009317
-1,377.00
-109.90%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-16.014430685565
2695.2051390504
-2,711.00
-100.59%
Cash Flow from Investing Activities
-25.8935693346702
-807.706587315083
782.00
96.79%
Cash Flow from Financing Activities
-109.802952490472
-2278.51956967137
2,169.00
95.18%
Net Cash Inflow / Outflow
-151.368889646412
-372.775540839392
221.00
59.39%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.342062864295553
18.2454770966604
-18.00
-98.13%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -120.41% vs -59.17% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-16.01
78.47
-120.41%






